“Our smart-clothing technology is designed to detect cancer at the earliest stages. It uses a non-invasive, painless method based on frequent ultrasound monitoring,” says Hugo Vuillet, one of the students on the development team at the Federal Institute of Technology Lausanne (EPFL).
The students came up with their design last autumn, working with IcosaMed, a Neuchâtel-based start-up founded in March 2019, according to EPFLExternal link. Their system proved so effective that the company decided to continue the partnership.
Unlike existing cancer-detection technology that uses radiation, IcosaMed’s technology emits ultrasound waves to perform echography scans for potentially cancerous cells. The ultrasound waves are generated using piezoelectric sensors, which are devices that run on energy generated when pressure is applied to a piezoelectric material. “This technology is what allows us to miniaturize the SmartBra’s detection system so that it’s still comfortable to wear and nearly imperceptible,” says Vuillet. If the system detects a suspicious mass of cells, it will alert the wearer so that she can schedule an appointment with a specialist.
“Our system could do more than detect cancer – we hope that one day it could also act preventively and emit nearly continuous, low-dose ultrasound waves in a controlled manner so as to stimulate apoptosis in the cancerous mass,” says IcosaMed founder and CEO Max Boysset. Apoptosis refers to the process of cell self-destruction.
Market launch planned for 2021
EPFL says the “SmartBra” will initially be sold to women who have already been diagnosed with cancer, so that they can monitor their condition on a daily basis. This will then be expanded to include women with a genetic predisposition to developing cancer, and eventually to all women.
“Right now we are in the process of raising funds. We need a total of CHF 4 million ($4.1 million): CHF 1.5 million to finalize the functional prototype we are building with high-tech manufacturer Turck duotechExternal link, and CHF 2.5 million for the initial market launch, currently planned for 2021,” says Boysset.
EPFL says that if everything goes according to plan, “the SmartBra could pave the way for other high-potential products using smart textiles – like underwear and bodysuits – to detect and prevent other types of cancers”.
More
More
Swiss cancer research yields breast-saving fat, better detection
This content was published on
The incidence of breast cancer in Switzerland is high, but research offers hope – especially the finding that cancer cells can be converted into fat.
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
Swiss federal prosecutor bemoans shortage of investigators
This content was published on
The Swiss Office of the Attorney General complains of unresolved shortage of investigators that hinder its efforts to prosecute serious criminals.
ECHR condemns Swiss failure to protect woman from violence
This content was published on
Switzerland did not provide a woman with sufficient protection against her partner who had been violent in the past, rules the ECHR.
This content was published on
In Switzerland, 2.2 million people are affected by non-communicable diseases, partly because people are not eating a balanced diet.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
A cancer diagnosis a long way from home
This content was published on
About 40% of Geneva's residents are non-Swiss, and many speak English. ESCA helps expats diagnosed with cancer understand their treatment options.
New ultrasound technique improves breast cancer detection
This content was published on
Zurich-based researchers have developed a new ultrasound technique that can help distinguish benign breast tumours from malignant ones.
This content was published on
Over the past five decades, the Federal Institute of Technology in Lausanne (EPFL) has been the home of many scientific discoveries.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.